

Airtime: ET
Novo Nordisk's shares fell sharply Thursday despite the insulin-maker reporting better-than-expected third-quarter earnings and raising its outlook for the full year. CFO Jesper Brandgaard said he sees "our top line next year to be negatively impacted … from currencies … and that has a negative impact on the share-price performance."

